Management ChangeApr 30, 2026, 04:44 PM
TELA Bio Board Refreshment; Q1 Revenue ~$19.0M, Beats Guidance
AI Summary
TELA Bio, Inc. announced a comprehensive board refreshment plan, with four current directors stepping down and four new highly accomplished executives joining after the 2026 Annual Meeting on June 9, 2026. Joseph Capper is expected to serve as the new Chair of the Board. The company also reported preliminary Q1 2026 revenue of approximately $19.0 million, surpassing its previously provided guidance of $18.5 million.
Key Highlights
- Four directors to step down after 2026 Annual Meeting on June 9, 2026.
- Four new directors appointed: Joseph Capper (expected Chair), Guy Nohra, Joseph Neels, Paul Thomas.
- Preliminary Q1 2026 revenue approximately $19.0 million.
- Preliminary Q1 2026 revenue exceeded previous guidance of approximately $18.5 million.
- Full Q1 2026 financial results to be reported on May 12, 2026.